| Before switching to IBN | After switching to IBN | |
| After oral BP (T2) | 6 months | 12 months |
Number with less than MSC (16.3%) in serum NTX |
|
|
|
vs. T1 (%) | 14 (100%) | 9 (64.3%) | 8 (57.1%) |
vs. T2 (%) |
| 3 (21.4%) | 5 (35.7%) |
Number with less than MSC (9.0%) in serum BAP |
|
|
|
vs. T1 (%) | 11 (78.6%) | 7 (50.0%) | 7 (50.0%) |
vs. T2 (%) |
| 3 (21.4%) | 3 (21.4%) |